Infant cerebral palsy, Polyclinic Gemini heads of a study on an innovative drug
ROMA (ITALPRESS) – The Fondazione Policlinico Universitario Agostino Gemelli IRCCS announces the start of the first Phase 2 study on the therapy with ashegermin (rhNGF, Nerve Growth Factor human recombinant) in children with cerebral palsy (CP – Cerebral Palsy), authorized […]
Infant cerebral palsy, Polyclinic Gemini heads of a study on an innovative drug Read More »










